Option Care Health, Inc. (NASDAQ:OPCH) Stake Boosted by Intech Investment Management LLC

Intech Investment Management LLC lifted its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 72.4% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 63,113 shares of the company's stock after purchasing an additional 26,513 shares during the quarter. Intech Investment Management LLC's holdings in Option Care Health were worth $1,975,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in OPCH. Massachusetts Financial Services Co. MA purchased a new position in Option Care Health during the second quarter worth approximately $68,003,000. Victory Capital Management Inc. raised its position in shares of Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company's stock worth $50,756,000 after buying an additional 1,585,818 shares during the period. Magnetar Financial LLC raised its position in shares of Option Care Health by 124.8% in the 2nd quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company's stock worth $68,750,000 after buying an additional 1,377,929 shares during the period. Duquesne Family Office LLC boosted its holdings in Option Care Health by 172.8% in the second quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company's stock valued at $51,849,000 after acquiring an additional 1,185,613 shares during the last quarter. Finally, Geneva Capital Management LLC purchased a new stake in Option Care Health during the third quarter valued at about $24,679,000. Hedge funds and other institutional investors own 98.05% of the company's stock.

Option Care Health Stock Up 1.2 %

OPCH stock traded up $0.28 during trading on Monday, reaching $23.41. The stock had a trading volume of 364,530 shares, compared to its average volume of 1,536,040. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.63. The firm has a fifty day moving average price of $27.62 and a 200 day moving average price of $29.09. The company has a market capitalization of $3.98 billion, a P/E ratio of 19.44, a PEG ratio of 2.39 and a beta of 1.32.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on OPCH shares. Truist Financial reduced their price objective on Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research note on Friday, November 1st. Bank of America lowered shares of Option Care Health from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. JMP Securities upped their price target on shares of Option Care Health from $36.00 to $37.00 and gave the stock a "market outperform" rating in a research report on Monday, September 30th. Jefferies Financial Group lowered Option Care Health from a "buy" rating to a "hold" rating and cut their price objective for the company from $38.00 to $26.00 in a research report on Thursday, October 31st. Finally, Barrington Research decreased their target price on Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a research report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $30.83.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business's stock in a transaction dated Friday, November 8th. The shares were acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the purchase, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.